Profit with us in the 2009 bear market
Research Report
Hotstocked.com has a complete research report available for RGEN stock. Download RGEN report.
Research Report
Get the full report for FREE
Date:Aug 12, 2009
Price:Free
Pages:5
Document Type:Adobe Acrobat Reader
 Download RGEN report
  
Example preview: Research report for Repligen Cp (RGEN) Research report for Repligen Cp (RGEN) Research report for Repligen Cp (RGEN) Research report for Repligen Cp (RGEN)
   

Profile for Repligen Cp (RGEN)

Markets Quote Depth/LII Options Charts News Company Financials Insiders Filings Analyst Earnings Historical
Profile ·  Share Information ·  Key Ratios
Symbol:  | Recent Quotes powered by
  quotemedia.com
Profile for Repligen Corp.  (RGEN) 
$ 4.76   0.04 (+0.85%) Volume: 46.66 k 4:00 PM EST Nov 20, 2009
After Hours:  $ 4.74   -0.02 (-0.42%) Volume: 100 4:00 PM EST Nov 20, 2009
Business Description:
A biopharmaceutical company, focused primarily on the development of novel therapeutics for radiology and neuropsychiatry.
Address: 41 Seyon Street, Building #1, Suite 100, Waltham, MA 02453
Telephone: (781) 250-0111 Website: www.repligen.com
Facsimile: (781) 250-0115 Email: investors@repligen.com
Details
CEO: Dr. Walter C. Herlihy, Ph.D.
Employees: 69 MarketCap: 146.41 m
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: UQ
Indices: Biotechnology , Russell 2000
Industry Classifications
Sector: Healthcare CIK: 0000730272
Industry: Drugs
Sub-Industry:    Biotechnology
NAICS: Biological Product (except Diagnostic) Manufacturing (325414)
SIC: Commercial Physical And Biological Research (8731) , Biological Products, Except Diagnostic Substances (2836)

Copyright © QuoteMedia.   Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).   RT   Realtime,  DL+   Realtime BATS,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia, profiles by Morningstar.  Terms of Use. 
   
 
Home > Companies > Repligen Cp